Corrigendum to “A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients” The Lancet Regional Health—Western Pacific, Volume 55 (2025), 101464
Titel:
Corrigendum to “A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients” The Lancet Regional Health—Western Pacific, Volume 55 (2025), 101464
Auteur:
Hiromatsu, Yuji Ishikawa, Eri Kozaki, Ai Takahashi, Yasuhiro Tanabe, Mika Hayashi, Ken Imagawa, Yukihiro Kaneda, Kazutoyo Mimura, Masashi Dai, Xiaoxian Hayashida, Tomoko Akamizu, Takashi